Remicade Infusion Management Program (RemiTRAC)
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Pointe-Claire, Canada
-
-
Quebec
-
Montreal, Quebec, Canada
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subject is a good candidate to receive infliximab as per the Product Monograph
- Subject is prescribed infliximab by an appropriate physician
- Subject receives infusion in a community infusion centre.
- Subject has signed the approved consent form.
Exclusion Criteria:
- Not specified in the protocol
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Type and frequency of infusion reactions
Time Frame: Up to 7 years
|
Up to 7 years
|
|
Pre-infusion treatments and efficacy
Time Frame: Up to 7 years
|
Up to 7 years
|
|
Infusion reaction management approaches
Time Frame: Up to 7 years
|
Up to 7 years
|
|
The number of subjects with adverse events
Time Frame: Up to 7 years
|
Up to 7 years
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CR100746
- P04466 (Other Identifier: Janssen Inc.)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.